Biological E receives DCGI approval for administration of Corbevax in children aged 12 to 18 years, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Corbevax is India’s first indigenously developed Receptor Binding Domain (RBD) Protein subunit vaccine against COVID-19. The vaccine had already received approval for restricted use in emergency situations among adults., Corbevax is India’s first indigenously developed Receptor Binding Domain (RBD) Protein subunit vaccine against COVID-19. The vaccine had already received approval for restricted use in emergency situations among adults., , Read More